8:10am ET
Health and Healthcare
Top Analyst Has 3 Large Cap Biotechs to Buy as Massive Selling Subsides
With indiscriminate selling absolutely punishing some of the top large cap biotech stocks, one analyst says now is the time to buy.
GILD Coverage Page 19
9:15am ET
Health and Healthcare
Major Biotechs See Rising Tide of Short Interest
The January 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, GE, Gilead, Humana, Oasis Petroleum, Sprint, Wynn, Yelp, Zynga and More
The top analyst upgrades, downgrades and other research calls from Thursday include Apple, GE, Gilead, Humana, Oasis Petroleum, Sprint, Wynn, Yelp and Zynga.
10:25am ET
Investing
Disney, Tesla, Twitter and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Disney, General Motors, Twitter and other major companies scheduled to report their quarterly results this week.
8:50am ET
Health and Healthcare
Major Biopharma Catalysts on February’s FDA Calendar
24/7 Wall St. has included a calendar of a some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Abbott Labs, Alphabet, Amazon, GE, Gilead, Intel, Seagate, US Steel and Many More
The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Alphabet, Amazon.com, General Electric, Gilead Sciences, Intel, Seagate Technology and U.S. Steel.
4:08pm ET
Investing
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a down day for the U.S. markets. Although the markets have been pushing new highs recently, today was not one of those days. Crude oil started the week out on…
9:20am ET
Health and Healthcare
Top Stocks to Look For in February’s FDA Calendar
Johnson &; Johnson, Gilead Sciences and Amicus Therapeutics are among companies expecting clinical trial and FDA updates in February.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Bed Bath & Beyond, Caterpillar, FirstEnergy, Gilead, Intel, Starbucks, Yamana Gold and More
The top analyst upgrades, downgrades and other research calls from Friday include Bed Bath & Beyond, Caterpillar, FirstEnergy, Gilead Sciences, Intel, Starbucks and Yamana Gold.
10:05am ET
Health and Healthcare
Short Sellers Raise the Stakes in Major Biotechs
The January 12 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
4:15pm ET
Investing
Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash
Apple indicated that it will pay $38 billion in repatriation taxes under the new tax law. Apple says that it is already the largest U.S. taxpayer and that a payment of that…
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Amazon, Boeing, Chesapeake Energy, Eli Lilly, Gilead, Micron, NVIDIA, P&G, Qualcomm and More
The top analyst upgrades, downgrades and other research calls from Tuesday include Amazon.com, Boeing, Chesapeake Energy, Eli Lilly, Gilead Sciences, Micron Thecnology, NVIDIA, Procter & Gamble and Qualcomm.
9:50am ET
Health and Healthcare
Short Sellers Grow More Selective on Major Biotechs
The December 29 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
11:15am ET
Health and Healthcare
Meet Merrill Lynch’s Top Biotech Picks for 2018
Merrill Lynch believes that this could be the year biotechs break out. The firm has a few picks, bad and good, that it believes will play a big role in the coming…
10:15am ET
Health and Healthcare
Analysts Have 12 Top Biotech Picks for Big Upside in 2018
There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be one.